|1.||Kim, Hae-Yeong: 2 articles (05/2011 - 12/2009)|
|2.||Lee, Jin: 2 articles (05/2011 - 12/2009)|
|3.||Kim, Young-Rok: 2 articles (05/2011 - 12/2009)|
|4.||Park, Cheon-Seok: 1 article (05/2011)|
|5.||Batt, Carl A: 1 article (05/2011)|
|6.||Jung, Sung-Geun: 1 article (05/2011)|
|7.||Kim, Han-Nah: 1 article (12/2009)|
|8.||Rehm, Bernd H A: 1 article (12/2009)|
|9.||Parlane, Natalie A: 1 article (12/2009)|
|10.||Buddle, Bryce M: 1 article (12/2009)|
05/15/2011 - "PHB nanoparticles loaded with model drug molecule, Nile red, were prepared through oil-in-water emulsion solvent evaporation method and the surface of nanoparticles were functionalized with tumor-specific ligand, RGD4C, fused with PHA synthase that drove the coupling reaction. "
12/14/2009 - "A biopolymer-based nanocarrier with cancer targeting capability was successfully synthesized from genetically engineered PHA synthase fused with RGD peptide."
12/01/2009 - "The biopolyester beads were engineered to display a fusion protein of the polyester synthase PhaC and the two key antigens involved in immune response to the infectious agent that causes tuberculosis, Mycobacterium tuberculosis, notably antigen 85A (Ag85A) and the 6-kDa early secreted antigenic target (ESAT-6) from Mycobacterium tuberculosis. "
|4.||Contagious Ecthyma (Orf)